Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79381 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Glyburide Related Compound B (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS)
CAS :Sulfonamides, excluding drugsFormule :C18H19ClN2O6SCouleur et forme :PowderMasse moléculaire :426.06524Modafinil Sulfone
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C15H15NO3SCouleur et forme :White Off-White PowderMasse moléculaire :289.07726Exemestane Related Compound A (6-Methyleneandrosta-4-ene-3,17-dione)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without othFormule :C20H26O2Couleur et forme :PowderMasse moléculaire :240.0Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS :Acyclic monoamines and their derivatives, nesoiFormule :C3H9NO3SCouleur et forme :PowderMasse moléculaire :139.03031Amoxicillin Related Compound B (L-amoxicillin)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19O5N3SCouleur et forme :PowderMasse moléculaire :365.10454Dexketoprofen Tromethamine
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C16H14O3·C4H11NO3Couleur et forme :White PowderMasse moléculaire :375.16819Ethambutol Related Compound A ((2R,2'S)-2,2'-[ethane-1,2-diylbis(azanediyl)]dibutan-1-ol)dihydrochloride)
CAS :Amino-alcohols, other than those containing more than oFormule :C10H24N2O2Couleur et forme :White PowderMasse moléculaire :204.183781-Mononitroglycerin
CAS :Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFormule :C3H7NO5Couleur et forme :Clear Colorless LiquidMasse moléculaire :137.03242Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H18N2O3SCouleur et forme :PowderMasse moléculaire :270.10381Proguanil Related Compound G (1-(3-chlorophenyl)-5-isopropylbiguanide hydrochloride)
CAS :Aromatic imines and their derivatives, salts thereofFormule :C11H16ClN5·HClCouleur et forme :White Crystalline PowderMasse moléculaire :253.10942Iodixanol Related Compound D (5-[Acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C20H28I3N3O9Couleur et forme :White PowderMasse moléculaire :834.89597Cefprozil Related Compound D ((6R,7R)-7-amino-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O3SCouleur et forme :White Off-White PowderMasse moléculaire :240.05686Ursodiol Related Compound H (3β, 7β-Dihydroxy-5β-cholan-24-oic acid)
CAS :Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormule :C24H40O4Couleur et forme :White Fine PowderMasse moléculaire :392.29266Imiquimod Related Compound D (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H14N4Couleur et forme :Off-White PowderMasse moléculaire :226.12185Diethyltoluamide Related Compound A (N,N-Diethyl-4-toluamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C12H17NOCouleur et forme :White CrystalsMasse moléculaire :191.13101Famciclovir Related Compound F (2-Amino-6-chloropurine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C5H4ClN5Couleur et forme :Light Yellow Off-White PowderMasse moléculaire :169.01552Topotecan Related Compound A ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C24H25N3O6Couleur et forme :SolidMasse moléculaire :451.17434Memantine Related Compound C (1-Chloro-3,5-dimethyladamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C12H19ClCouleur et forme :Light Yellow LiquidMasse moléculaire :198.11753Benzhydrol
CAS :Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C13H12OCouleur et forme :White Off-White PowderMasse moléculaire :184.08882Cyclizine Related Compound A (1-Methylpiperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C5H12N2Couleur et forme :Colorless Clear Pale Yellow LiquidMasse moléculaire :100.10005Haloperidol Related Compound A (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H36Cl2N2O3Couleur et forme :White PowderMasse moléculaire :566.2103Sumatriptan Succinate Related Compound A ([3-[2-(Dimethylamino)ethyl]-2-[[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl]-1H-indol-5-yl]-N-methylmethanesulfonamide succinate salt)
Sulfonamides, nesoiFormule :C27H37N5O2S·C4H6O4Couleur et forme :White PowderMasse moléculaire :495.2668Povidone
CAS :Other vinyl polymers in primary forms,nesoiFormule :(C6H9NO)nCouleur et forme :PowderMasse moléculaire :10000 - 70000Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H10ClNOCouleur et forme :Light Yellow PowderMasse moléculaire :243.04509Fluorouracil Related Compound A (Pyrimidine-2,4,6(1H,3H,5H)-trione)
CAS :Malonylurea (barbituric acid) and its saltsFormule :C4H4N2O3Couleur et forme :White PowderMasse moléculaire :128.022194-Hydroxyindole (1H-Indol-4-ol)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C8H7NOCouleur et forme :Light Yellow Light Grey Crystalline PowderMasse moléculaire :133.05276Sulindac Related Compound B ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C20H17FO4SCouleur et forme :Yellow Crystalline PowderMasse moléculaire :372.08316Prilocaine Related Compound A (o-Toluidine hydrochloride)
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H9N·HClCouleur et forme :Grey PowderMasse moléculaire :143.05018Granisetron Related Compound E ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C9H18N2·C2H4O2Couleur et forme :Off-White PowderMasse moléculaire :154.147Fosinopril Related Compound D ((4R)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C30H45NNaO7PCouleur et forme :White PowderMasse moléculaire :585.28313Lamotrigine Related Compound B (2,3-dichlorobenzoic acid)
CAS :Aromatic monocarboxylic acids, their anhydrides, halideFormule :C7H4Cl2O2Couleur et forme :Beige PowderMasse moléculaire :189.95883Phthalazine
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C8H6N2Couleur et forme :Light Yellow PowderMasse moléculaire :130.0531Ethambutol Related Compound B (((2R,2'R)-2,2'-[Ethane-1,2-diylbis(azanediyl)]dibutan-1-ol) dihydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C10H24N2O2·2HClCouleur et forme :White SolidMasse moléculaire :204.18378Glimepiride Related Compound C ((Methyl ({4-[2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl]phenyl}sulfonyl)carbamate)
CAS :Sulfonamides, nesoiFormule :C18H23N3O6SCouleur et forme :White Crystalline PowderMasse moléculaire :409.13076Diphenhydramine Related Compound A (2-(Diphenylmethoxy)-N-methylethanamine hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C16H19NO·HClCouleur et forme :White Crystalline PowderMasse moléculaire :241.14666Flumazenil Related Compound B (Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-a][1,4]benzodiazepine-3-carboxylate)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H15N3O4Couleur et forme :White PowderMasse moléculaire :301.10626Clarithromycin Impurity D (N-desmethyl clarithromycin)
CAS :Lactones nesoiFormule :C37H67NO13Couleur et forme :White Off-White PowderMasse moléculaire :733.46124Timolol Related Compound B (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H24N4O3SCouleur et forme :White Off-White PowderMasse moléculaire :316.15691Febuxostat
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C16H16N2O3SCouleur et forme :White Off-White PowderMasse moléculaire :316.08816Lamotrigine Related Compound D (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C16H9Cl4N5OCouleur et forme :White PowderMasse moléculaire :426.95612Ribavirin Related Compound A (1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C8H11N3O6Couleur et forme :White Off-White PowderMasse moléculaire :245.06479Metoclopramide Related Compound D (Methyl 4-acetamido-2-methoxybenzoate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H13NO4Couleur et forme :White Off-White PowderMasse moléculaire :223.08446Iohexol Related Compound A (5-(acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C16H20I3N3O7Couleur et forme :Off-White PowderMasse moléculaire :746.84354Carmustine Related Compound A (1,3-bis(2-chloroethyl)urea)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C5H10Cl2N2OCouleur et forme :White PowderMasse moléculaire :184.01702Memantine Related Compound I (3-Ethyladamantan-1-amine hydrochloride)
CAS :Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereofFormule :C12H21N·HClCouleur et forme :White PowderMasse moléculaire :215.14408Aminocaproic Acid Related Compound A (6-(6-Aminohexanamido)hexanoic acid)
CAS :Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormule :C12H24N2O3Couleur et forme :White Crystalline PowderMasse moléculaire :244.17869Sorbitol
CAS :D-glucitol (sorbitol)Formule :C6H14O6Couleur et forme :White Crystalline PowderMasse moléculaire :182.17 g/molTriclocarban Related Compound C (1,3-Bis(3,4-dichlorophenyl)urea)
CAS :Ureines and their derivatives; salts thereofFormule :C13H8Cl4N2OCouleur et forme :White Off-White PowderMasse moléculaire :347.93907Fosinopril Related Compound G ((4-phenylbutyl)phosphinyl acetic acid, disodium salt)
CAS :Organo-inorganic compounds, nesoiFormule :C12H15Na2O4PCouleur et forme :Off-White PowderMasse moléculaire :300.05033Abacavir Related Compound B ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C10H14ON4ClCouleur et forme :Cream PowderMasse moléculaire :241.08561Ethosuximide Related Compound A (2-Ethyl-2-methylsuccinic acid)
CAS :Acyclic polycarboxylic acids and their anhydrides, halides, peroxides and their derivatives, nesoiFormule :C7H12O4Couleur et forme :White PowderMasse moléculaire :160.07356Ketorolac Related Compound B (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H13NO2Couleur et forme :Yellow SolidMasse moléculaire :227.09463Zolpidem Related Compound A (N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide)
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C19H21N3OCouleur et forme :Off-White PowderMasse moléculaire :307.16846Desloratadine Related Compound A (8-Bromo-6,11-dihydro-11-(piperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C19H19BrN2Couleur et forme :Light Yellow PowderMasse moléculaire :354.07316Propantheline Bromide Related Compound A (9-Hydroxypropantheline bromide)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C23H30BrNO4Couleur et forme :White PowderMasse moléculaire :463.13582Propofol Related Compound C (2,6-diisopropylphenyl isopropyl ether)
CAS :Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C15H24OCouleur et forme :LiquidMasse moléculaire :220.18272Chlordiazepoxide Related Compound A (7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide)
CAS :Antidepressants, tranquilizers and other psychotherapeutic agents, nesoiFormule :C15H11ClN2O2Couleur et forme :White PowderMasse moléculaire :286.05091Pyrazinamide Related Compound B (Pyrazinecarbonitrile)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C5H3N3Couleur et forme :White PowderMasse moléculaire :105.0327Tiotropium Related Compound F (Di(thiophen-2-yl)methanone)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C9H6OS2Couleur et forme :Colorless Off-White SolidMasse moléculaire :193.98601Furosemide Related Compound B (4-Chloro-5-sulfamoylanthranilic Acid)
CAS :Sulfonamides, nesoiFormule :C7H7ClN2O4SCouleur et forme :White Yellow PowderMasse moléculaire :249.98151Darifenacin Related Compound G (5-(2-Bromoethyl)-2,3-dihydrobenzofuran)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C10H11BrOCouleur et forme :White Pale Yellow PowderMasse moléculaire :225.99933Tacrolimus Related Compound A (See USP Certificate for full Chemical Name)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C43H69NO12Couleur et forme :White Light Yellow PowderMasse moléculaire :791.48198Epoprostenol Related Compound A (7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxyoct-1-enyl]cyclopentyl}-6-oxoheptanoic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C20H34O6Couleur et forme :White PowderMasse moléculaire :370.23554Tropicamide Related Compound A (N-(pyridin-4-ylmethyl)ethanamine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C8H12N2Couleur et forme :LiquidMasse moléculaire :136.10005Hydroxyzine Related Compound A (1-[(4-Chlorophenyl)phenylmethyl]piperazine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C17H19ClN2Couleur et forme :PowderMasse moléculaire :286.12368Lorazepam Related Compound A (7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-acetoxy-2H-1,4-benzodiazepin-2-one)
CAS :Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H12Cl2N2O3Couleur et forme :Off-White PowderMasse moléculaire :362.0225Diclofenac Alcohol
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C13H11Cl2NOCouleur et forme :White PowderMasse moléculaire :267.02177Adapalene Related Compound E (2,2'-Binaphthyl-6,6'-dicarboxylic acid)
CAS :Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFormule :C22H14O4Couleur et forme :PowderMasse moléculaire :342.08921Iopamidol Related Compound C (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C17H22ClI2N3O8Couleur et forme :White PowderMasse moléculaire :684.91849Amifostine Disulfide (1,3-Propanediamine, N,N-(dithiodi-2,1-ethanediyl)bis, tetrahydrochloride)
CAS :Organo-sulfur compounds, nesoiFormule :C10H30N4S2Cl4Couleur et forme :White PowderMasse moléculaire :410.0666Trazodone Related Compound C (2-{3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl}-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H22ClN5O·HClCouleur et forme :Off-White PowderMasse moléculaire :371.15129Cyclosporine
CAS :Lactams, nesoiFormule :C62H111N11O12Couleur et forme :White PowderMasse moléculaire :1201.84137Piroctone Related Compound B (4-methyl-6-(2,4,4-trimethylpentyl)-2H-pyran-2-one)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) onlyFormule :C14H22O2Couleur et forme :Colorless LiquidMasse moléculaire :222.16198Dipyridamole Related Compound D (2,2'-({6-[(2-Hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl}azanediyl)diethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C22H36N8O3Couleur et forme :Yellow PowderMasse moléculaire :460.29104Frovatriptan Related Compound A ((R)-3-Amino-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C13H15N3OCouleur et forme :Off-White SolidMasse moléculaire :229.12151Dipyridamole Related Compound A (2,2'-{[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C25H40N8O2Couleur et forme :Yellow PowderMasse moléculaire :484.32742Nepafenac Related Compound B (7-Benzoylindolin-2-one)
CAS :Lactams not elsewhere specified or includedFormule :C15H11NO2Couleur et forme :Pink SolidMasse moléculaire :237.07898Doxazosin Related Compound F (N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H22N2O6Couleur et forme :White Off-White PowderMasse moléculaire :410.14779Terazosin Related Compound C (1,4-Bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine, dihydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C24H28N8O4·2HClCouleur et forme :Off-White PowderMasse moléculaire :492.22335Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C13H18Cl2N2·ClHCouleur et forme :White PowderMasse moléculaire :308.06138Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C20H24N2Couleur et forme :Pale Yellow SolidMasse moléculaire :292.19395Timolol Related Compound E ((S,Z)-4-({1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-yl}oxy)-4-oxobut-2-enoic acid maleate salt (1:1)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H26N4O6S·C4H4O4Couleur et forme :Off-White PowderMasse moléculaire :414.15731Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS :Imides and their derivatives (excluding sacharin), and salts thereofFormule :C9H7NO2Couleur et forme :White Off-White SolidMasse moléculaire :161.04768Flunixin Related Compound C (Ethyl 2-chloronicotinate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C8H8ClNO2Couleur et forme :Clear LiquidMasse moléculaire :185.02436Loratadine Related Compound A (8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C19H19ClN2Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :310.12368Ziprasidone Related Compound D (3-(Benzo[d]isothiazol-3-yl)-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindolin-2-one)
Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormule :C28H24ClN5OS2Couleur et forme :Light Yellow Yellow PowderMasse moléculaire :545.11108Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS :Compounds containing an unfused imidazole ring (whetherFormule :C20H20Cl4N6Couleur et forme :White Off-White PowderMasse moléculaire :486.23Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C20H24ClN3S·2HClCouleur et forme :Light Grey PowderMasse moléculaire :373.13795Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C32H43NO6Couleur et forme :Light Grey Blue PowderMasse moléculaire :537.30904Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29BrN4O5Couleur et forme :Cream PowderMasse moléculaire :568.13213Deferasirox System Suitability Mixture (A mixture containing Deferasirox, Benzoxazinone analog, Deferasirox ethyl ester, Deferasirox 1,2-isomer, Deferasirox 1,3-isomer and Salicylimide)
Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroCouleur et forme :White PowderTigecycline Related Compound B ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x))
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C23H28N4O7·HClCouleur et forme :Off-White PowderMasse moléculaire :472.1958Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C8H9ClN4O2Couleur et forme :White Off-White PowderMasse moléculaire :228.0414Oxazepam Related Compound B (7-Chloro-2-oxo-5-phenyl-2,3-dihydro-1H-benzodiazepin-3-yl acetate)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroFormule :C17H13ClN2O3Couleur et forme :PowderMasse moléculaire :328.06147Betamethasone Dipropionate Related Compound C (9-Fluoro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate)
CAS :Halogenated derivatives of adrenal cortical hormonesFormule :C25H33FO6Couleur et forme :White PowderMasse moléculaire :448.22612Fentanyl Related Compound A ((2-bromoethyl)benzene)
CAS :Halogenated derivatives of aromatic hydrocarbons not elFormule :C8H9BrCouleur et forme :LiquidMasse moléculaire :185.07 g/molRisedronate Related Compound A ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C7H11NO7P2·H2OCouleur et forme :White Crystalline PowderMasse moléculaire :301.01164Granisetron Related Compound A (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H24N4OCouleur et forme :White Off-White PowderMasse moléculaire :312.19501Bendamustine Related Compound D (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoic acid hydrochloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C14H18ClN3O2HClCouleur et forme :Pink SolidMasse moléculaire :332.23Almotriptan Related Compound B (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate)
CAS :Aromatic or modified aromatic drugs with nitrogen heteroFormule :C15H21N3O2S·C4H4O4Couleur et forme :PowderMasse moléculaire :307.13545Sotalol Related Compound B (N-(4-Formylphenyl)methanesulfonamide)
CAS :Sulfonamides, nesoiFormule :C8H9NO3SCouleur et forme :Yellow Crystalline PowderMasse moléculaire :199.03031Atovaquone Related Compound A (cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone)
CAS :Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormule :C22H19ClO3Couleur et forme :Yellow Crystalline PowderMasse moléculaire :366.84Methylphenidate Related Compound A (α-Phenyl-2-piperidineacetic Acid Hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C13H17NO2·HClCouleur et forme :White PowderMasse moléculaire :255.10261Irinotecan Related Compound D ((R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C33H38N4O6·HCl·3H2OCouleur et forme :White Light Yellow PowderMasse moléculaire :677.19Trospium Chloride Related Compound C ((1R, 3r, 5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8, 1'-pyrrolidinium]chloride)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C11H20ClNOCouleur et forme :White SolidMasse moléculaire :217.12334β-Methylcholine Chloride (2-Hydroxy-N,N,N-trimethylpropan-1-aminium chloride)
CAS :Quaternary ammonium salts and hydroxides, whether or not chemically defined, otherFormule :C6H16ClNOCouleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :153.09204Raloxifene Related Compound C (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C28H27NO5SCouleur et forme :Yellow PowderMasse moléculaire :489.16099Adrenalone Hydrochloride
CAS :Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFormule :C9H11NO3·HClCouleur et forme :White Beige PowderMasse moléculaire :217.05057Bupivacaine Related Compound A (6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide) (AS)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C18H30N2OCouleur et forme :White Off-White PowderMasse moléculaire :290.23581Risperidone Related Compound G (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C23H28FN3O3Couleur et forme :Off-White PowderMasse moléculaire :413.21147Moxifloxacin Related Compound F (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C22H26FN3O4Couleur et forme :Off-White Yellow Tan PowderMasse moléculaire :415.19073Desogestrel Related Compound D (13-Ethyl-11-methylenegon-4-en-17-one)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without other oxygen function not elsewhere specified or includedFormule :C20H28OCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :284.21402Urea
CAS :Urea, whether or not in aqueous solutionFormule :CH4N2OCouleur et forme :White Powder CrystalsMasse moléculaire :60.03236Rivaroxaban Open Ring S-isomer ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20ClN3O4SCouleur et forme :White Off-White SolidMasse moléculaire :409.0863Diatrizoic Acid Related Compound A (5-Acetamido-3-amino-2,4,6-triiodobenzoic Acid)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C9H7I3N2O3Couleur et forme :Off-White Light Yellow PowderMasse moléculaire :571.75908Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS :Nitrile function compounds, not elsewhere specified or includedFormule :C12H9F3N2O2Couleur et forme :White Off-White PowderMasse moléculaire :270.06161Indole
CAS :Acridine (10-azaanthracene) and indole (2,3-benzopyrrole)Formule :C8H7NCouleur et forme :White Crystalline PowderMasse moléculaire :117.05785Azithromycin Related Compound F (3'-N-Demethyl-3'-N-formylazithromycin)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C38H70N2O13Couleur et forme :White PowderMasse moléculaire :762.48779Bendamustine Related Compound H (4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H-benzimidazol-2-yl]butanoic acid)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C32H41Cl3N6O4Couleur et forme :Off-White Yellow Orange SolidMasse moléculaire :678.22549Atenolol Related Compound G (2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl}acetic acid)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C14H21NO4Couleur et forme :White SolidMasse moléculaire :267.147065-Phenylhydantoin
CAS :Hydantoin and its derivativesFormule :C9H8N2O2Couleur et forme :PowderMasse moléculaire :176.05858Lufenuron Related Compound C (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide)
CAS :Ureines and their derivatives; salts thereofFormule :C17H9ClF8N2O3Couleur et forme :SolidMasse moléculaire :476.0174Gatifloxacin Related Compound A (1-Cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C18H20FN3O4Couleur et forme :Yellow SolidMasse moléculaire :361.14378Paclitaxel Impurity Mixture (This mixture contains paclitaxel and paclitaxel benzyl analog)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :Green Grey PowderGlycopyrrolate Related Compound L (Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate)
CAS :Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormule :C14H18O3Couleur et forme :Translucent Light Yellow Liquid ViscousMasse moléculaire :234.12559Nicardipine Related Compound B (3-{2-[Benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate oxalate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C26H27N3O6·C2H2O4Couleur et forme :Off-White SolidMasse moléculaire :567.18529Ticlopidine Related Compound B (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H12ClNOSCouleur et forme :White PowderMasse moléculaire :277.03281Zidovudine Related Compound C (thymine)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C5H6N2O2Couleur et forme :PowderMasse moléculaire :126.04293Quetiapine Related Compound H (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H25N3O3SCouleur et forme :PowderMasse moléculaire :399.16166Cephalexin Related Compound F ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H17N3O4SCouleur et forme :White Off-White PowderMasse moléculaire :347.09398Valsartan Related Compound C (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C31H35N5O3Couleur et forme :White PowderMasse moléculaire :525.27399Vecuronium Bromide Related Compound F (Piperidinium,1-[(2β,3α,5α,16β,17β)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H55BrN2O3Couleur et forme :White Off-White PowderMasse moléculaire :594.33961Pimobendan Related Compound B (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C19H20N4O3Couleur et forme :White Off-White PowderMasse moléculaire :352.15354Valproic Acid Related Compound A (2-allylpent-4-enoic acid)
CAS :Unsaturated acyclic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives, nesoiFormule :C8H12O2Couleur et forme :Clear LiquidMasse moléculaire :140.08373Sulfamethoxazole Related Compound A (N-{4-[N-(5-methylisoxazol-3-yl)sulfamoyl]phenyl}acetamide)
CAS :Sulfonamides, nesoiFormule :C12H13N3O4SCouleur et forme :White Crystalline PowderMasse moléculaire :295.06268Nifedipine Nitrophenylpyridine Analog (Dimethyl 4-(2-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H16N2O6Couleur et forme :White Yellow PowderMasse moléculaire :344.100842-Amino-5-chlorobenzophenone
CAS :Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormule :C13H10ClNOCouleur et forme :Yellow Crystalline PowderMasse moléculaire :231.04509Nimodipine Related Compound A (2-methoxyethyl-1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H24N2O7Couleur et forme :LiquidMasse moléculaire :416.15835Paliperidone Related Compound B (6-fluoro-3-(piperidin-4-yl)benzoisoxazole hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H13FN2OCouleur et forme :White PowderMasse moléculaire :220.10119Sibutramine Related Compound A (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
Aromatic monoamines not elsewhere specified or includedFormule :C17H26ClN·HCl·H2OCouleur et forme :White Crystalline PowderMasse moléculaire :334.3Diclofenac Potassium
CAS :Aromatic amino-acids and their esters,other than those containing more than one kind of oxygen function for use as drugsFormule :C14H10Cl2KNO2Couleur et forme :White Light Yellow Crystalline PowderMasse moléculaire :332.97257Rabeprazole Related Compound A (Sodium 1-(1H-benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H9N3NaxO3Couleur et forme :Off-White Yellow PowderMasse moléculaire :313.04393Temozolomide Related Compound A (4-diazo-4H-imidazole-5-carboxamide)
CAS :Compounds containing an unfused imidazole ring (whetherFormule :C4H3N5OCouleur et forme :PowderMasse moléculaire :137.03376Testosterone Related Compound C (17α-Hydroxyandrost-4-en-3-one)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C19H28O2Couleur et forme :PowderMasse moléculaire :288.20893Abacavir Sulfate Racemic (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol sulfate (2:1))
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :(C14H18N6O)2·H2SO4Couleur et forme :Off-White PowderMasse moléculaire :670.2758Cefuroxime Axetil E-isomers ((1RS,6R,7R)-1-Acetoxyethyl 3-[(carbamoyloxy)methyl]-7-[(E)-2-(furan-2-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22N4O10SCouleur et forme :Pale Yellow PowderMasse moléculaire :510.10566Cefprozil (Z)-Isomer
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19N3O5S·H2OCouleur et forme :PowderMasse moléculaire :389.10454Quetiapine Related Compound B (11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C17H17N3S·2HClCouleur et forme :Off-White PowderMasse moléculaire :295.11432Irinotecan Related Compound C (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl (1,4'-bipiperidine)- 1'-carboxylate hydrochloride)
CAS :Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFormule :C32H36N4O6·HClCouleur et forme :Yellow PowderMasse moléculaire :608.24016Pioglitazone Hydrochloride
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C19H20N2O3S·HClCouleur et forme :White PowderMasse moléculaire :356.11946Irbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C25H30N6O2Couleur et forme :White PowderMasse moléculaire :446.24302Azaerythromycin A (9-Deoxo-9a-aza-9a-homoerythromycin A)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C37H70N2O12Couleur et forme :White PowderMasse moléculaire :734.49288Cefadroxil Related Compound I ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS :Aminoglycoside antibioticsFormule :C16H17N3O5SCouleur et forme :Off-White PowderMasse moléculaire :363.08889Fenoldopam Related Compound B (1-(4-Hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol methanesulfonate)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C16H17NO3·CH4SO3Couleur et forme :Off-White PowderMasse moléculaire :271.12084Amlodipine Related Compound F (Dimethyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate maleate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C19H23ClN2O5·C4H4O4Couleur et forme :Off-White PowderMasse moléculaire :394.12955Atenolol Related Compound B (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C11H15NO4Couleur et forme :White PowderMasse moléculaire :225.10011Dronedarone Related Compound B ((5-Amino-2-butylbenzofuran-3-yl){4-[3-(dibutylamino)propoxy]phenyl}methanone, dihydrochloride)
CAS :Aromatic pesticides with oxygen heteroFormule :C30H42N2O3·2HClCouleur et forme :SolidMasse moléculaire :550.2729Irinotecan Related Compound B ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C22H20N2O5Couleur et forme :Yellow Off-White PowderMasse moléculaire :392.13722Prasugrel Related Compound D (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18FNO2SCouleur et forme :Off-White PowderMasse moléculaire :331.10423Cefprozil L-Epimer ((6R,7R)-7-[(S)-2-amino-2-(4-hydroxyphenyl)acetamido]-8-oxo-3-[(Z)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H19N3O5SCouleur et forme :PowderMasse moléculaire :389.10454Atenolol Related Compound A (2-(4-Hydroxyphenyl)acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C8H9NO2Couleur et forme :Light Cream PowderMasse moléculaire :151.06333Fluoxetine Related Compound C (4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C21H22F3NO4Couleur et forme :PowderMasse moléculaire :409.41Dopamine Related Compound B (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFormule :C9H13NO2·HClCouleur et forme :Off-White SolidMasse moléculaire :203.07131Methylene Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbut-3-enoate)
CAS :Lactones nesoiFormule :C25H36O5Couleur et forme :White PowderMasse moléculaire :416.25627Apixaban Related Compound H (Ethyl 6-[4-(5-chloropentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS :Lactams, nesoiFormule :C27H29ClN4O5Couleur et forme :Off-White PowderMasse moléculaire :524.18265Entacapone Related Compound A ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide)
CAS :Nitrile function compounds, nesoiFormule :C14H15N3O5Couleur et forme :Dark Orange PowderMasse moléculaire :305.10117Glycopyrrolate Related Compound B (1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate Hydrochloride)
CAS :Aromatic polycarboxylic acids, their anhydrides, halideFormule :C18H25NO3Couleur et forme :Off-White PowderMasse moléculaire :339.86Amlodipine Related Compound K (Ethyl 6-(2-chlorophenyl)-8-methyl-3,4,6,7-tetrahydro-2H-benzo[b][1,4]oxazine-5-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H18ClNO3Couleur et forme :PowderMasse moléculaire :331.09752Glipizide Related Compound C (1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]urea)
CAS :Sulfonamides, nesoiFormule :C21H27N5O4SCouleur et forme :White Off-White PowderMasse moléculaire :445.17838Ganciclovir Mono-N-methyl Valinate (2-(RS)-[(Guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C15H24N6O5·xHClCouleur et forme :White PowderMasse moléculaire :404.1575Famciclovir Related Compound C (4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C12H17N5O2Couleur et forme :White Light Yellow PowderMasse moléculaire :263.13822Glimepiride Related Compound A (1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(cis-4-methylcyclohexyl)urea)
CAS :Sulfonamides, nesoiFormule :C24H34N4O5SCouleur et forme :White PowderMasse moléculaire :490.22499Chloroxylenol Related Compound A (2-chloro-3,5-dimethylphenol)
CAS :Derivatives containing only halogen substitutes and theFormule :C8H9ClOCouleur et forme :White FlakesMasse moléculaire :156.03419Dextromethorphan Related Compound C (3-Methoxy-17-methyl-9 α,13 α,14 α-morphinan-10-one)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C18H23NO2Couleur et forme :Light Yellow SolidMasse moléculaire :285.17288Moexipril Related Compound E ((S)-6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, hydrochloride)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C12H15NO4·HClCouleur et forme :PowderMasse moléculaire :237.10011Ceftazidime δ-3-Isomer
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H22N6O7S2Couleur et forme :Yellow Off-White Crystalline PowderMasse moléculaire :546.09914Flutamide Related Compound A (4-nitro-3-(trifluoromethyl)aniline)
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H5F3N2O2Couleur et forme :PowderMasse moléculaire :206.03031Methimazole Related Compound A (2,2-Dimethoxy-N-methylethanamine)
CAS :Amino-alcohols, other than those containing more than oneFormule :C5H13NO2Couleur et forme :Colorless Light Yellow LiquidMasse moléculaire :119.09463Metoclopramide Related Compound A (4-Acetamido-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C16H24ClN3O3Couleur et forme :Off-White PowderMasse moléculaire :341.15062Doxapram Related Compound B (1-Ethyl-4-{2-[(2-hydroxyethyl)amino]ethyl}-3,3-diphenylpyrrolidin-2-one hydrochloride)
CAS :Lactams, nesoiFormule :C22H29CIN2O2Couleur et forme :White Off-White PowderMasse moléculaire :492.12738Antipyrine Related Compound A (3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one)
CAS :Aromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structureFormule :C10H10N2OCouleur et forme :White Pale Yellow PowderMasse moléculaire :174.07931Chloroquine Related Compound G (4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-amine oxide sulfate)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ringFormule :C18H26ClN3O·H2SO4Couleur et forme :Yellow PowderMasse moléculaire :433.14382Bosentan Related Compound B (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C25H25N5O5SCouleur et forme :White PowderMasse moléculaire :507.15764Lorazepam Related Compound E (6-Chloro-4-(o-chlorophenyl)-2-quinazoline methanol)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C15H10Cl2N2OCouleur et forme :White PowderMasse moléculaire :304.01702Xylometazoline Related Compound A (N-(2-Aminoethyl)-2-[4-(tert-butyl)-2,6-dimethylphenyl]acetamide)
CAS :Sulfonamides used as drugsFormule :C16H26N2OCouleur et forme :Off-White SolidMasse moléculaire :262.20451Cromolyn Related Compound A (1,3-Bis(2-acetyl-3-hydroxyphenoxy)propan-2-ol)
CAS :Ketone-phenols and ketones with other oxygen functionFormule :C19H20O7Couleur et forme :Off-White PowderMasse moléculaire :360.1209Bisacodyl Related Compound C (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H17NO3Couleur et forme :SolidMasse moléculaire :319.12084Cetirizine Related Compound B (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H24N2O·2HClCouleur et forme :PowderMasse moléculaire :368.14222Ibuprofen Related Compound C (4-isobutylacetophenone)
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C12H16OCouleur et forme :Clear Colourless To Light Yellow LiquidMasse moléculaire :176.12012Irinotecan Related Compound A ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C20H16N2O5Couleur et forme :Light Yellow PowderMasse moléculaire :364.10592Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS :Aromatic pesticides with oxygen hetero-atom(s) only neFormule :C20H23FN2O2Couleur et forme :Cream PowderMasse moléculaire :342.17436Captopril Disulfide
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C18H28N2O6S2Couleur et forme :White Solid Crystalline PowderMasse moléculaire :432.13888Bendamustine Related Compound C (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C18H27N3O4Couleur et forme :White PowderMasse moléculaire :349.20016Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C29H26ClN3O8SCouleur et forme :White Off-White SolidMasse moléculaire :611.11291Azathioprine Related Compound G (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C9H8N8O2SCouleur et forme :PowderMasse moléculaire :292.04909Fexofenadine Related Compound B (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate)
Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C32H39NO4·HCl·H2OCouleur et forme :White PowderMasse moléculaire :555.27515Haloperidol Related Compound B (4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(2-fluorophenyl)butan-1-one)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C21H23ClFNO2Couleur et forme :White Off-White PowderMasse moléculaire :375.14013Oseltamivir Related Compound A ((3S,4R,5S)-Ethyl 4-acetamido-5-amino-2-azido-3-(pentan-3-yloxy)cyclohexanecarboxylate)
CAS :Cyclic amides and their derivatives, nesoiFormule :C16H29N5O4Couleur et forme :White PowderMasse moléculaire :355.22195Econazole Related Compound C (1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]imidazolium chloride)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C25H21Cl5N2OCouleur et forme :White PowderMasse moléculaire :540.00965Trisalicylic Acid
CAS :Esters of salicylic acid and its salts not elsewhere specified or includedFormule :C21H14O7Couleur et forme :White PowderMasse moléculaire :378.07395
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
![Lamotrigine Related Compound D (N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichloro…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1356790.webp&w=3840&q=75)
![Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1692710.webp&w=3840&q=75)
![Raloxifene Related Compound C (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phe…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1598234.webp&w=3840&q=75)
![Risperidone Related Compound G (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604756.webp&w=3840&q=75)
![Quetiapine Related Compound H (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]pi…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1592792.webp&w=3840&q=75)
![Abacavir Sulfate Racemic (4-[2-amino-6-(cyclopropylamino)-9H-purin-9yl]-2-cyclopentene-1-methanol …](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1000419.webp&w=3840&q=75)
![Glipizide Related Compound C (1-cyclohexyl-3-[[4-[2-[[(6-methylpyrazin-2-yl)carbonyl]amino]ethyl]p…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1292631.webp&w=3840&q=75)
